Literature DB >> 25938626

Microangiopathy triggers, and inducible nitric oxide synthase exacerbates dextran sulfate sodium-induced colitis.

Hiroki Saijo1, Norifumi Tatsumi2, Seiji Arihiro3, Tomohiro Kato4, Masataka Okabe2, Hisao Tajiri5, Hisashi Hashimoto2.   

Abstract

Ulcerative colitis (UC) is a representative clinical manifestation of inflammatory bowel disease that causes chronic gastrointestinal tract inflammation. Dextran sulfate sodium (DSS)-induced colitis mice have been used to investigate UC pathogenesis, and in this UC model, disturbance and impairment of the mucosal epithelium have been reported to cause colitis. However, how DSS sporadically breaks down the epithelium remains unclear. In this study, we focused on the colonic microcirculation and myenteric neurons of DSS-induced colitis. Moreover, we examined the potential of myenteric neurons as a target to prevent exacerbation of colitis. Fluorescent angiographic and histopathological studies revealed that DSS administration elicited blood vessel disruption before epithelial disorders appeared. Ischemic conditions in the lamina propria induced inducible nitric oxide synthase (iNOS) expression in myenteric neurons as colitis aggravated. When neuronal activity was inhibited with butylscopolamine, neuronal iNOS expression decreased, and the exacerbation of colitis was prevented. These results suggested that DSS-induced colitis was triggered by microcirculatory disturbance in the mucosa, and that excessive neuronal excitation aggravated colitis. During remission periods of human UC, endoscopic inspection of the colonic microcirculation may enable the early detection of disease recurrence, and inhibition of neuronal iNOS expression may prevent the disease from worsening.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25938626     DOI: 10.1038/labinvest.2015.60

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  56 in total

Review 1.  HIF-1 as a target for drug development.

Authors:  Amato Giaccia; Bronwyn G Siim; Randall S Johnson
Journal:  Nat Rev Drug Discov       Date:  2003-10       Impact factor: 84.694

Review 2.  Confocal laser endomicroscopy: technical advances and clinical applications.

Authors:  Helmut Neumann; Ralf Kiesslich; Michael B Wallace; Markus F Neurath
Journal:  Gastroenterology       Date:  2010-06-15       Impact factor: 22.682

Review 3.  Confocal laser endomicroscopy: technical status and current indications.

Authors:  A Hoffman; M Goetz; M Vieth; P R Galle; M F Neurath; R Kiesslich
Journal:  Endoscopy       Date:  2006-12       Impact factor: 10.093

Review 4.  Genetics and pathogenesis of inflammatory bowel disease.

Authors:  Bernard Khor; Agnès Gardet; Ramnik J Xavier
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

5.  Role of inducible nitric oxide synthase in dextran sulphate sodium-induced colitis.

Authors:  Y Yoshida; A Iwai; K Itoh; M Tanaka; S Kato; R Hokari; T Miyahara; H Koyama; S Miura; M Kobayashi
Journal:  Aliment Pharmacol Ther       Date:  2000-04       Impact factor: 8.171

6.  Muscarinic receptor subtype-3 gene ablation and scopolamine butylbromide treatment attenuate small intestinal neoplasia in Apcmin/+ mice.

Authors:  Jean-Pierre Raufman; Jasleen Shant; Guofeng Xie; Kunrong Cheng; Xue-Min Gao; Brian Shiu; Nirish Shah; Cinthia B Drachenberg; Jonathon Heath; Jürgen Wess; Sandeep Khurana
Journal:  Carcinogenesis       Date:  2011-06-24       Impact factor: 4.944

7.  Osteopontin attenuation of dextran sulfate sodium-induced colitis in mice.

Authors:  Andre Paes Batista da Silva; Richard P Ellen; Esben S Sørensen; Harvey A Goldberg; Ron Zohar; Jaro Sodek
Journal:  Lab Invest       Date:  2009-08-10       Impact factor: 5.662

8.  Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis.

Authors:  Minoru Matsuura; Kazuichi Okazaki; Akiyoshi Nishio; Hiroshi Nakase; Hiroyuki Tamaki; Kazushige Uchida; Toshiki Nishi; Masanori Asada; Kimio Kawasaki; Toshiro Fukui; Hazuki Yoshizawa; Shinya Ohashi; Satoko Inoue; Chiharu Kawanami; Hiroshi Hiai; Yasuhiko Tabata; Tsutomu Chiba
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

9.  Dextran sulfate sodium (DSS)-induced colitis in mice.

Authors:  Benoit Chassaing; Jesse D Aitken; Madhu Malleshappa; Matam Vijay-Kumar
Journal:  Curr Protoc Immunol       Date:  2014-02-04

10.  Neutralizing anti-vascular endothelial growth factor (VEGF) antibody reduces severity of experimental ulcerative colitis in rats: direct evidence for the pathogenic role of VEGF.

Authors:  Ganna Tolstanova; Tetyana Khomenko; Xiaoming Deng; Longchuan Chen; Andrzej Tarnawski; Amrita Ahluwalia; Sandor Szabo; Zsuzsanna Sandor
Journal:  J Pharmacol Exp Ther       Date:  2008-12-05       Impact factor: 4.030

View more
  10 in total

1.  Nailfold Capillaroscopy as a Biomarker in the Evaluation of Pediatric Inflammatory Bowel Disease.

Authors:  Jacob A Kurowski; Sonal R Patel; Joshua B Wechsler; Marisa R Izaguirre; Gabrielle A Morgan; Lauren M Pachman; Jeffrey B Brown
Journal:  Crohns Colitis 360       Date:  2021-10-29

2.  Quercetin Attenuates Adhesion Molecule Expression in Intestinal Microvascular Endothelial Cells by Modulating Multiple Pathways.

Authors:  Yifei Bian; Ping Liu; Jia Zhong; Yusheng Hu; Shen Zhuang; Kai Fan; Zhongjie Liu
Journal:  Dig Dis Sci       Date:  2018-08-04       Impact factor: 3.199

3.  SLC26A3 (DRA) prevents TNF-alpha-induced barrier dysfunction and dextran sulfate sodium-induced acute colitis.

Authors:  Xiangming Ding; Dongxiao Li; Mengke Li; Han Wang; Qin He; Yunwu Wang; Hongbing Yu; Dean Tian; Qin Yu
Journal:  Lab Invest       Date:  2018-01-12       Impact factor: 5.662

4.  Effects of initiating time and dosage of Panax notoginseng on mucosal microvascular injury in experimental colitis.

Authors:  Shi-Ying Wang; Ping Tao; Hong-Yi Hu; Jian-Ye Yuan; Lei Zhao; Bo-Yun Sun; Wang-Jun Zhang; Jiang Lin
Journal:  World J Gastroenterol       Date:  2017-12-21       Impact factor: 5.742

Review 5.  Targeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors.

Authors:  Ana P S Silva; Priscila V Coelho; Maristella Anazetti; Patricia U Simioni
Journal:  Hum Vaccin Immunother       Date:  2016-11-10       Impact factor: 3.452

6.  Panax notoginseng Promotes Repair of Colonic Microvascular Injury in Sprague-Dawley Rats with Experimental Colitis.

Authors:  Shiying Wang; Ping Tao; Lei Zhao; Wangjun Zhang; Hongyi Hu; Jiang Lin
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-29       Impact factor: 2.629

7.  Qingchang Suppository Ameliorates Colonic Vascular Permeability in Dextran-Sulfate-Sodium-Induced Colitis.

Authors:  Boyun Sun; Jianye Yuan; Shiying Wang; Jiang Lin; Wanjun Zhang; Jiadong Shao; Ruiqing Wang; Bei Shi; Hongyi Hu
Journal:  Front Pharmacol       Date:  2018-10-31       Impact factor: 5.810

8.  Papaverine adjuvant therapy for microcirculatory disturbance in severe ulcerative colitis complicated with CMV infection: a case report.

Authors:  Yu Tian; Yue Zheng; Jinpei Dong; Jixin Zhang; Huahong Wang
Journal:  Clin J Gastroenterol       Date:  2019-04-03

Review 9.  Imaging of the Intestinal Microcirculation during Acute and Chronic Inflammation.

Authors:  Kayle Dickson; Hajer Malitan; Christian Lehmann
Journal:  Biology (Basel)       Date:  2020-11-26

10.  CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma.

Authors:  Young Chang; Yun Bin Lee; Eun Ju Cho; Jeong-Hoon Lee; Su Jong Yu; Yoon Jun Kim; Jung-Hwan Yoon
Journal:  BMC Cancer       Date:  2020-10-15       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.